Rethinking How America Treats Opioid Addiction
Get the full intelligence
Search transcripts, export clips, track mentions, and explore all topics from “Rethinking How America Treats Opioid Addiction” inside PodZeus.
In this powerful episode of the Cato Podcast, host Jeff Miron speaks with Helen Redmond, a Harlem-based filmmaker, clinical social worker, and senior editor at Filter, about her new book *Liquid Handcuffs*, which critically examines the U.S. opioid treatment program (OTP) system. Redmond argues that methadone clinics—often called opioid treatment programs—are better described as 'opioid treatment prisons' due to their deeply carceral structure, including supervised dosing, mandatory urine tests, and strict control over medication access. She traces the origins of this system to the Nixon administration, revealing how it was historically used as a racially targeted crime control mechanism, disproportionately affecting Black urban communities under the guise of public health. The episode delves into the role of the DEA in policing treatment, the stigmatization of medication-assisted treatment, and the systemic barriers that prevent equitable access—such as NIMBYism, profit-driven clinics, and the lack of enforcement of federal guidelines allowing take-home doses. Despite some progress during the pandemic, Redmond emphasizes that real reform requires decoupling treatment from law enforcement, expanding prescriber access beyond OTPs, and integrating methadone into mainstream healthcare, as done in Canada, the UK, and Australia—though even those systems retain significant surveillance and stigma. The conversation culminates in a call for abolition of the current OTP model and a vision of humane, accessible, and dignified care. Key takeaways include: 1) The OTP system is rooted in racialized criminalization and should be reimagined as a public health model; 2) The DEA’s role in treatment undermines medical ethics and deters providers; 3) Take-home medication policies remain inconsistent due to clinic discretion and financial incentives; 4) Expanding access to methadone prescribing beyond OTPs—through primary care, pharmacies, and harm reduction centers—is essential for equity; 5) Even 'successful' international models still involve surveillance, highlighting that true liberation requires more than access—it demands dignity. The episode concludes with a strong advocacy for systemic change to end the cycle of control and punishment in addiction treatment.
Methadone clinics function as 'opioid treatment prisons' due to extreme surveillance, power imbalances, and punitive rules that violate medical ethics.
The OTP system originated in the Nixon era as a racially targeted crime control strategy, not a public health initiative.
The DEA’s involvement in treatment creates a chilling effect on providers, discouraging prescribing due to fear of scrutiny and legal action.
Take-home medication policies are inconsistently implemented because clinics have financial incentives to maintain daily visits.
True reform requires integrating methadone into mainstream healthcare, expanding prescriber access beyond OTPs, and ending the criminalization of addiction.
Introducing Helen Redmond and the Core Thesis
“I call them opioid treatment prisons... because staff control access to your medication. You don't control access to it. You're never 100% in control of your medication.”
The Carceral Nature of Methadone Clinics
“They control your movements. They control everything that you do. And staff in clinics do as well.”
Historical Roots: Nixon, Race, and Crime Control
“If we can associate black people with heroin and we can associate cannabis with the hippies, we can really disrupt their communities.”
The DEA’s Role in Medical Treatment
The episode critiques the DEA’s involvement in prescribing and monitoring methadone and buprenorphine, highlighting how their presence normalizes policing within healthcare and deters providers from prescribing.
The Myth of Buprenorphine as a 'White' Treatment
Redmond discusses how buprenorphine was historically positioned as suitable for white, middle-class patients, while methadone was seen as appropriate for the urban underclass—revealing deep racialized assumptions in treatment access.
“If we can associate black people with heroin and we can associate cannabis with the hippies, we can really disrupt their communities.”
“I call them opioid treatment prisons... because staff control access to your medication. You don't control access to it. You're never 100% in control of your medication.”
“The DEA, we have to get them out of treatment. And until we do, you know, the lives of health care providers are going to be really difficult.”
Host
Guest
Helen Redmond
person
Methadone
product
Jeff Miron
person
Drug Enforcement Administration
organization
Buprenorphine
product
Nixon administration
organization
Substance Abuse and Mental Health Services Administration
organization
Fentanyl
product
Liquid Handcuffs
book
Canadian healthcare system
other
Congressional Feuding and Airport Chaos
Cato Podcast • 22m • 3/31/2026
The Great Political Realignment
Cato Podcast • 52m • 4/2/2026
Birthright Citizenship on Trial
Cato Podcast • 48m • 4/7/2026
Orbán's Hungary: Model or Cautionary Tale?
Cato Podcast • 47m • 4/9/2026
Who Actually Pays Federal Taxes?
Cato Podcast • 24m • 4/14/2026
Get the full intelligence
Search transcripts, export clips, track mentions, and explore all topics from “Rethinking How America Treats Opioid Addiction” inside PodZeus.
Start discovering podcast insights today
Start with a 7-day trial and explore a growing catalog of popular podcasts. No credit card required.
No credit card required • 7-day trial • Cancel anytime
